Lead sponsor
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
4 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
4
Trials led
3
Ongoing
6,658
Total enrollment
314
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 3
1
Phase 4
3
Trials by status
Recruiting
1
Active, not recruiting
2
Suspended
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)Age ≥18Ph 4Active, not recruiting2,500
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Diseasemild-to-moderate ADPh 4Recruiting1,312